The invention relates to a beta-
amyrin synthase
mutant and application of the beta-
amyrin synthase
mutant in preparation of dammarendiol, and belongs to the technical field of genes. The beta-
amyrin alcohol synthase
mutant is subjected to the following
amino acid mutation on a sequence as shown in SEQ ID NO: 75: M240L, and other
amino acid sequences are kept unchanged; or M240L, Q483V, and other
amino acid sequences are kept unchanged; the amino acid sequences are M240L, L251F, M253F and Q483V, or M240L, L251F, M253F and Q483V, and other amino acid sequences are kept unchanged; the amino acid sequences are M240L, L251F, M253F, L325V, Q483V and G491A, or M240L, L251F, M253F, L325V, Q483V and G491A, and other amino acid sequences are kept unchanged; the amino acid sequence of the
gene can be L128T, M240L, L251F, M253F, L325V, V375S, Q483V or G491A, or other amino acid sequences are kept unchanged. According to the invention,
mutation of key amino acids is determined through site-
directed mutagenesis and site-
directed mutagenesis of beta-AS, so that beta-AS has the function of catalytically generating dammarendiol.